Ahhh yes.
The better way.
What's better than doing a trial the FDA wants?
Not doing a trial? Just looking at some more data from the trial the FDA thought was insufficient in the first place?
Piecing together some real world data that is prone to bias, is much lower quality evidence?
Wow MSB sure is crafty, maybe they'll teach the FDA a thing or two.
2023 The Final Countdown, page-2667
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
0.060(5.83%) |
Mkt cap ! $1.244B | |||
| Open | High | Low | Value | Volume |
| $1.04 | $1.10 | $1.03 | $4.925M | 4.571M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7260 | $1.09 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.10 | 67541 | 7 |
View Market Depth
| Last trade - 16.10pm 26/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |